The overall growth has been pricing-led with material cost inflation eating into the company’s profitability. There has been a 24% jump in raw material costs and a 20% increase in other expenses over the same quarter a year earlier. The management, in the company’s earnings call, mentioned 2022 inflation being five times the past trend.
Nifty Pharma, 4 others hit 52-week high since Iran war while Nifty fell 7%. Will the form continue?
Despite a challenging market backdrop fueled by geopolitical tensions and foreign fund outflows, five Indian sectors—Pharma, Energy, Defence, Capital Markets, and Metals—are showing remarkable strength.
May 25, 2026